Ultraexpensive gene therapies, industry interests and the right to health: the case of onasemnogene abeparvovec in Brazil

por Ivama-Brummell, Adriana Mitsue, Wagner, Anita K, Pepe, Vera Lúcia Edais, Naci, Huseyin
Publicado 2022